← All Sponsors
SPONSOR

Kamada, Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Alpha 1-Antitrypsin Deficiency
NCT04204252 Phase 3
Recruiting

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Alpha 1-Antitrypsin Deficiency
Belgium, Finland, Ireland View Trial →